Genmab — Februar 2017
-
Ja, se side 24 i regnskabet. 12 -20%
-
20% på alt over 3 mia USD i et kalenderår
-
ved i hvad USD er indregnet til i 2017?
-
er det 690-695?
-
Hvert år starter forfra, begyndende med 12%, og med 20% på alt over 3 mia USD
-
næh vent nu lidt - Jan siger faktisk direkte, at en højere royaltysats bliver triggered med 1,3 mia. Han kan dog ikke sige, hvor stor en sats og heller ikke ved hvilket omsætningstal
-
Genmab-boss efter rekordregnskab: Vi er tæt på at blive et ikonisk selskab
Biotekselskabet Genmab leverede for fjerde år i træk overskud. Nu lander der over 1 mia. kr. i kassen, hvilket ikke mindst skyldes vidundermidlet Darzalex.
Finans (finans.dk)
-
En god gennemgang af begivenheder i 2017: http://borsen.dk/nyheder/virksomheder/artikel/1/340560/genmab-boss_her_er_de_vigtigste_succeskriterier_i_2017.html
-
Enig Lego.
-
-
We know at least that for 2016 Darzalex sales of USD572mm we received royalties of DKK458mm. If I use an FX rate of 6.67, that gets us to exactly 12% royalty. Looking at where USDDKK traded last year, I think it is a fair guess that USD500mm did not trigger a step up yet.
-
On page 94 of the annual report they show some forward contracts they have to sell USD into EUR based on anticipated quarterly royalty payments from Janssen. That is for a total of USD42mm until February 2018. If someone can find out what % of their earnings they hedge, we can calculate how much earnings they expect
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind